Evidence map›Paper›PMID 20382709›Full record

ArticleThe American journal of pathology2010

TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells.

Ya-Wen Chen, Ming-Shyue Lee, Amanda Lucht, Feng-Pai Chou, Wei Huang, Thomas C Havighurst, KyungMann Kim, Jehng-Kang Wang, Toni M Antalis, Michael D Johnson and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 3 syntheses or guidelines pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Ya-Wen ChenGreenebaum Cancer Center, University of Maryland Baltimore, Baltimore, MD 21201, USA.
Ming-Shyue Lee
Amanda Lucht
Feng-Pai Chou
Wei Huang
Thomas C Havighurst
KyungMann Kim
Jehng-Kang Wang
Toni M Antalis
Michael D Johnson
Chen-Yong Lin
University of Maryland, Baltimore · USUniversity of Wisconsin–Madison · USGeorgetown University · USNational Defense Medical Center · TWNational Taiwan University · TW

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Nihal Ahmad · 1985 to 2026
$142.6M
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Taofeek K Owonikoko · 2008 to 2026
$51.0M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1TR000101 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2015
$19.3M
Vascular Remodeling by Membrane Serine ProteasesR01HL084387 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2007 to 2010
$1.5M
Matriptase: Activation and Function in Breast CancerR01CA096851 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI LIN, CHEN-YONG · 2003 to 2007
$1.4M
Deregulation of Matriptase in Breast Cancer CellsR01CA104944 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI LIN, CHEN-YONG · 2004 to 2008
$1.4M
Protease Pathways in the Gastrointestinal TractR01DK081376 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2009 to 2010
$675k
NCATS NIH HHS UL1 TR000101NCI NIH HHS P30 CA014520NCI NIH HHS P30 CA134274NCI NIH HHS R01 CA 096851NCI NIH HHS R01 CA096851NCI NIH HHS R01 CA 104944NCI NIH HHS R01 CA104944
6 · The paper itself

Abstract

TMPRSS2, a type II transmembrane serine protease, is highly expressed by the epithelium of the human prostate gland. To explore the regulation and function of TMPRSS2 in the prostate, a panel of monoclonal antibodies with high sensitivity and specificity were generated. Immunodetection showed TMPRSS2 on the apical plasma membrane of the prostate luminal cells and demonstrated its release into semen as a component of prostasomes, organelle-like vesicles that may facilitate sperm function and enhance male reproduction. In prostate cancer cells, TMPRSS2 expression was increased and the protein mislocalized over the entire tumor cell membrane. In both LNCaP prostate cancer cells and human semen, TMPRSS2 protein was detected predominantly as inactive zymogen forms as part of an array of multiple noncovalent and disulfide-linked complexes, suggesting that TMPRSS2 activity may be regulated by unconventional mechanisms. Our data suggested that TMPRSS2, an apical surface serine protease, may have a normal role in male reproduction as a component of prostasomes. The aberrant cellular localization, and increased expression of the protease seen in cancer, may contribute to prostate tumorigenesis by providing access of the enzyme to nonphysiological substrates and binding-proteins.

Indexed as

Epithelial CellsAdultAgedAged, 80 and overAnimalsAntibodies, MonoclonalCell Line, TumorHumansMaleMiceMicroarray AnalysisMiddle AgedProstateProstatic NeoplasmsSemenSerine EndopeptidasesAntibodies, MonoclonalSerine EndopeptidasesTMPRSS2 protein, human

Identifiers

PMID20382709
PMCPMC2877858
OpenAlexW2087340528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.